Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Current Opinion in Microbiology|March 4, 2014
Macrophages clean up: efferocytosis and microbial controlConstance J Martin, Kristen N Peters, Samuel M BeharSeminars in Immunopathology|November 19, 2015
A bug's life in the granulomaConstance J Martin, Allison F Carey, Sarah M FortuneMicrobes and Infection|April 5, 2011
Lipids, apoptosis, and cross-presentation: links in the chain of host defense against Mycobacterium tuberculosisSamuel M Behar, Constance J Martin, Cláudio Nunes-Alves, et al.International Journal of Toxicology|March 19, 2021
Nonclinical Development of SRK-181: An Anti-Latent TGFβ1 Monoclonal Antibody for the Treatment of Locally Advanced or Metastatic Solid TumorsBrian T Welsh, Ryan Faucette, Sanela Bilic, et al.Mbio|May 11, 2017
Digitally Barcoding <i>Mycobacterium tuberculosis</i> Reveals <i>In Vivo</i> Infection Dynamics in the Macaque Model of TuberculosisConstance J Martin, Anthony M Cadena, Vivian W Leung, et al.Cell Host & Microbe|September 18, 2012
Efferocytosis is an innate antibacterial mechanismConstance J Martin, Matthew G Booty, Tracy R Rosebrock, et al.Plos Pathogens|October 13, 2018
Concurrent infection with Mycobacterium tuberculosis confers robust protection against secondary infection in macaquesAnthony M Cadena, Forrest F Hopkins, Pauline Maiello, et al.Plos Pathogens|May 7, 2015
Human and Murine Clonal CD8+ T Cell Expansions Arise during Tuberculosis Because of TCR SelectionCláudio Nunes-Alves, Matthew G Booty, Stephen M Carpenter, et al.Science Translational Medicine|March 28, 2020
Selective inhibition of TGFβ1 activation overcomes primary resistance to checkpoint blockade therapy by altering tumor immune landscapeConstance J Martin, Abhishek Datta, Christopher Littlefield, et al.Science Signaling|July 9, 2024
An antibody that inhibits TGF-β1 release from latent extracellular matrix complexes attenuates the progression of renal fibrosisJustin W Jackson, Frederick C Streich, Ajai Pal, et al.Pageof 1